Achondroplasia in children
Achondroplasia in children | |
---|---|
![]() | |
Synonyms | N/A |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Short stature, disproportionate dwarfism, macrocephaly, midface hypoplasia |
Complications | Spinal stenosis, obstructive sleep apnea, ear infections, hydrocephalus |
Onset | Infancy |
Duration | Lifelong |
Types | N/A |
Causes | Genetic mutation in the FGFR3 gene |
Risks | Advanced paternal age |
Diagnosis | Physical examination, genetic testing |
Differential diagnosis | Hypochondroplasia, thanatophoric dysplasia, pseudoachondroplasia |
Prevention | None |
Treatment | Growth hormone therapy, surgical intervention |
Medication | Vosoritide |
Prognosis | Generally good with management |
Frequency | 1 in 15,000 to 40,000 live births |
Deaths | Rare, usually related to complications |
Achondroplasia in Children
Achondroplasia is a genetic disorder that is a common cause of dwarfism. It affects the growth of bones, leading to a characteristic appearance that includes a short stature, disproportionately short arms and legs, a large head with a prominent forehead, and a flattened bridge of the nose. This article focuses on achondroplasia as it presents in children, including its causes, diagnosis, and management.
Causes
Achondroplasia is caused by a mutation in the FGFR3 gene (Fibroblast Growth Factor Receptor 3). This gene is crucial for the development and maintenance of bone and brain tissue. In achondroplasia, the mutation leads to an abnormal version of the FGFR3 protein, which interferes with the normal growth of cartilage into bone, particularly in the long bones of the arms and legs. The condition is inherited in an autosomal dominant pattern, meaning only one copy of the altered gene is sufficient to cause the disorder. However, most cases (about 80%) arise from new mutations in the gene and occur in families with no history of the condition.
Symptoms and Characteristics
Children with achondroplasia exhibit a number of distinctive physical features and health issues. These include:
- Short stature, with an adult height around 4 feet (122 cm) for both males and females.
- Disproportionately short limbs, especially the upper arms and thighs.
- A large head with a prominent forehead and a flattened nasal bridge.
- Spinal abnormalities such as lordosis (swayback) or kyphosis (hunchback).
- Frequent middle ear infections, which can lead to hearing loss.
- Breathing problems due to a small chest and issues with the upper airways.
Diagnosis
Diagnosis of achondroplasia in children can often be made based on physical characteristics and family history. Prenatal ultrasound can sometimes detect signs of the condition in the fetus. After birth, a definitive diagnosis is usually made through genetic testing to identify the mutation in the FGFR3 gene.
Management and Treatment
There is no cure for achondroplasia, but treatments are available to manage symptoms and prevent or address complications. Management strategies include:
- Monitoring and treating ear infections promptly to prevent hearing loss.
- Physical therapy to strengthen muscles and improve mobility.
- Orthopedic interventions, such as surgery, to correct bone abnormalities if necessary.
- Growth hormone therapy, which has been used in some cases to increase height, though its effectiveness is still under study.
- Supportive therapies to address breathing problems and sleep apnea.
Living with Achondroplasia
Children with achondroplasia can lead healthy, active lives with proper medical care and support. It is important for parents and caregivers to foster a positive self-image in the child and to educate them about their condition in an age-appropriate manner. Support groups and organizations for individuals with dwarfism can provide valuable resources and a sense of community.
Conclusion
Achondroplasia in children presents unique challenges, but with early diagnosis, comprehensive management, and supportive care, these children can grow up to lead fulfilling lives. Ongoing research into treatments and interventions offers hope for even better outcomes in the future.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD